Luxendo

About:

Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments.

Website: http://luxendo.eu

Twitter/X: luxendo

Top Investors: EQT Life Sciences, EMBLEM Technology Transfer, LSP BioVentures, EMBL Ventures

Description:

Luxendo will manufacture and sell advanced Single Plane Illumination Microscopes (SPIM) originally developed at EMBL by Lars Hufnagel and his team. SPIM is a rapidly emerging technology that combines optical sectioning with multiple-view imaging to observe tissues and living organisms with impressive resolution. Unlike the conventional techniques of widefield and confocal fluorescence microscopy, the light sheet technique illuminates on the region surrounding the focal plane of the detection objective in a twin objective configuration.

Total Funding Amount:

14M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Heidelberg, Baden-Wurttemberg, Germany

Founded Date:

2015-01-01

Contact Email:

info(AT)luxendo.eu

Founders:

Joachim Rothe

Number of Employees:

11-50

Last Funding Date:

2017-01-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai